Search

Search Constraints

You searched for: Author/Creator Agarwal, Roshan

Search Results

1. 2022-RA-1173-ESGO Follow-up in gynecological cancer survivors: an EORTC QLG-GCG survivorship study- trial in progress. (20th October 2022)

2. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019)

4. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Issue 10298 (31st July 2021)

6. Intravenous Versus Oral Dexamethasone Premedication in Preventing Paclitaxel Infusion Hypersensitivity Reactions in Gynecological Malignancies. Issue 7 (1st September 2013)